We believe we are taking on one of the biggest challenges of our lifetime, combining science, technology, and population-scale clinical studies to reveal cancer at its beginnings. To detect cancer early, when it can be cured.
It is our capability and our commitment that make us GRAIL Read More »
Everyone has been touched by cancer in some way, whether it’s a friend or family member facing a diagnosis, or their own worry about susceptibility to the disease. This year alone, roughly 1.8 million people will be diagnosed with cancer in the United States, according to the National Cancer Institute. We’re losing nearly 1,700 loved ones every day to
A Novel Early Detection Blood Test Could Soon Change How Cancer is Found Read More »
GRAIL’s blood-based multi-cancer detection test continues to advance since achieving a major milestone at last year’s ASCO Meeting For 45 years, the American Society of Clinical Oncology (ASCO) Annual Meeting has provided an opportunity to chart progress in the fight against cancer. Marked in its early days by steady advancements in chemotherapy and a growing
Entering a New Era of Early Cancer Detection Read More »
Biomedical innovation is occurring at an unparalleled rate. We have truly entered the era of precision medicine fueled by the genomic revolution. But despite the many advances made in oncology, cancer remains the number one cause of death in the United States among those 80 years of age and younger, and the second leading cause
Working to Transform Cancer Care Through Early Detection Read More »
As a medical oncologist, I’ve spent my career working to understand the genomic basis of cancer in order to develop molecular diagnostics that can help us detect and treat it. My ultimate mission has been to help detect cancer as early as possible – when it can be more successfully treated. Fueled by the latest
Striving for Earlier Cancer Detection Read More »
